| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503053 | Journal of the Neurological Sciences | 2017 | 4 Pages |
Abstract
In our study, mBc-based administration of RTX allowed personalizing treatment administration and in several cases to lower the cumulative dose without loss of efficacy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
M. Cohen, G. Romero, J. Bas, M. Ticchioni, M. Rosenthal, R. Lacroix, C. Brunet, A. Rico, J. Pelletier, B. Audoin, C. Lebrun,